Effective immediately, Jean-Pierre Robert becomes president of Draxis Specialty Pharmaceuticals (DSP), the company's wholly owned subsidiary for radiopharmaceutical, sterile, and nonsterile products. Robert previously served as president of Draximage, DSP's radiopharmaceutical division.
John Durham, currently president of Draxis Pharma, will leave the company effective July 20 to pursue other interests.
Draxis Health also restructured the office of the president to include both Dr. Martin Barkin, president and CEO of Draxis Health, and chief operating officer (COO) Dan Brazier. Barkin and Brazier will retain their current responsibilities.
By AuntMinnie.com staff writers
July 20, 2007
Draxis posts Q2 earnings estimate, July 20, 2007
Draxis hires DeChambre for business development, May 29, 2007
Draxis to join Nasdaq Biotechnology Index, May 16, 2007
Draxis grows Q1 revenues, net income, May 10, 2007
Draxis shows Q4, year-end strength, February 8, 2007
Copyright © 2007 AuntMinnie.com